Antihyperglycemic agent

An antihyperglycemic agent refers to a diverse group of pharmacological compounds used to treat elevated blood glucose levels, primarily in the context of diabetes mellitus [StatPearls: Antidiabetic Medications]. This term identifies a therapeutic class of drugs rather than a specific molecular target, meaning it represents a collection of medications that act on various biological receptors, enzymes, and transporters [NIH: Drugs for Diabetes]. Common mechanisms of action within this class include the stimulation of pancreatic insulin secretion, the enhancement of peripheral insulin sensitivity, and the inhibition of glucose absorption or reabsorption [PubMed: PMCID PMC4939297]. These agents are essential for maintaining glycemic control to prevent long-term complications such as cardiovascular disease, neuropathy, and kidney failure [Mayo Clinic: Diabetes treatment]. Due to the varied nature of these drugs, they are categorized into sub-classes like biguanides, sulfonylureas, SGLT2 inhibitors, and GLP-1 receptor agonists based on their specific biological interactions [ADA: Standards of Medical Care in Diabetes].

Other names

Antidiabetic agentHypoglycemic agentGlucose-lowering drugAntidiabetic medication

Varied mechanisms depending on the specific drug subclass, including activation of AMPK to inhibit hepatic gluconeogenesis, agonism of the GLP-1 receptor to stimulate insulin release, inhibition of SGLT2 to promote glucose excretion, and inhibition of DPP-4 to prolong incretin activity.